Prospective randomized controlled trial comparing low dose Prednisone(or
Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in
patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet
treated.
The Investigators hypothesize that low dose Prednisone(or Prednisolone)/Methotrexate
combination will be as effective as standard dose Prednisone(or Prednisolone), and result in
significantly better quality of life and less toxicity than standard dose Prednisone(or
Prednisolone).